Daniel A. Arber, M.D.
Donald West and Mary Elizabeth King Professor
Chairman, Department of Pathology
Dean Kenneth S. Polonsky, MD, is pleased to announce the appointment of Daniel A. Arber, MD, an internationally recognized hematopathologist, researcher and educator, as professor and chair of the Department of Pathology effective December 1, 2016.
An authority on the diagnosis and classification of acute myeloid leukemia, Dr. Arber joins us from Stanford University, where he was the Ronald F. Dorfman Professor in Pathology, vice chair for clinical services, senior associate chair for hematopathology and medical director of anatomic pathology and clinical laboratory services.
Dr. Arber’s research focuses on molecular genetic and immunophenotypic changes in blood cancers. He recently presented proposed changes to the 2016 World Health Organization (WHO) classification of myelodysplastic syndromes, including the incorporation of genetic changes, and was the lead author of a summary of the 2016 WHO classification of myeloid neoplasms and acute leukemias published earlier this year in Blood. He co-chaired a group of leading hematopathologists and hematologists who developed joint College of American Pathology/American Society of Hematology guidelines for the initial workup for acute leukemia, which will be presented in a spotlight session at the upcoming American Society of Hematology meeting and will be published in 2017. Dr. Arber is the author of more than 250 publications, book sections and chapters, and has edited a number of textbooks in the field.
A dedicated educator, he received the Stanford School of Medicine Teaching Excellence Award in 2009-2010 and 2011 and the Stanford University Medical Center Department of Pathology Clinical Pathology Senior Faculty Teaching Award in 2010.
We owe our deep gratitude to Vinay Kumar, MD, PhD, the Alice Hogge and Arthur A. Baer Distinguished Service Professor, who is stepping down after more than 16 years as department chair. Under his stewardship, the department has attracted robust NIH funding, expanded its clinical and research facilities, added a division of Genomic and Molecular Pathology, and attracted more than 40 new faculty members.
Please join Dr. Polonsky in thanking Vinay and welcoming Dan to our campus. We look forward to continued departmental growth and preeminence under his leadership.